Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Perrigo to Separate Rx Biz | Contract Pharma

What are you searching for?

Sign in
Breaking News

Perrigo to Separate Rx Biz

Will focus on expanding its consumer business

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Perrigo Company plc is separating its Prescription Pharmaceuticals (Rx) business following the company’s strategic portfolio review. According to the company, a separation of the Rx business will better enable this asset to capitalize on its platform of differentiated generic pharmaceutical products and allows Perrigo to focus on expanding its consumer business. The company is considering all options, including a possible separation to shareholders, a sale or merger.   

The Rx business provides ‘extended topicals’ medications to treat ailments at more affordable prices. The portfolio includes topical generic medicines in multiple dosage forms, including creams, foams, mousses, gels, liquids and inhalable products.

Chief executive officer, Uwe Roehrhoff said, “Today’s announcement to separate the Rx business enables management to focus on expanding our leading consumer businesses while unlocking potential value for shareholders. Committing our energy and capital to the healthcare needs of consumers and our retail and pharmacy partners better positions Perrigo to drive long-term growth. We look forward to providing a comprehensive update on our consumer businesses on a conference call scheduled for September 25, 2018.”

The separation is expected to be completed during 1H19, which may include a tax-efficient separation to shareholders, a sale or merger.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters